Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.
Company profile
Ticker
ELV
Exchange
Website
CEO
Gail Boudreaux
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ANTHEM INC, Anthem, Inc., WELLPOINT INC, WELLPOINT, INC
SEC CIK
Corporate docs
Subsidiaries
Advantage Medical Group, LLC • Alianza Medicos del SurEste, LLC • Alliance Care Management, LLC • American Imaging Management, Inc. • AMERIGROUP Community Care of New Mexico, Inc. • AMERIGROUP Corporation • Amerigroup Delaware, Inc. • Amerigroup District of Columbia, Inc. • Amerigroup Insurance Company • Amerigroup Iowa, Inc. ...
IRS number
352145715
ELV stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
4 Mar 24
S-8
Registration of securities for employees
23 Feb 24
10-K
2023 FY
Annual report
21 Feb 24
8-K
Other Events
25 Jan 24
8-K
Elevance Health Reports Results for Fourth Quarter
24 Jan 24
S-3ASR
Automatic shelf registration
1 Nov 23
10-Q
2023 Q3
Quarterly report
18 Oct 23
8-K
Elevance Health Reports Third Quarter 2023 Results
18 Oct 23
8-K
Regulation FD Disclosure
13 Oct 23
8-K
Amendments to Articles of Incorporation or Bylaws
5 Oct 23
Transcripts
ELV
Earnings call transcript
2023 Q4
24 Jan 24
ELV
Earnings call transcript
2023 Q3
18 Oct 23
ELV
Earnings call transcript
2023 Q2
19 Jul 23
ELV
Earnings call transcript
2023 Q1
19 Apr 23
ELV
Earnings call transcript
2022 Q4
25 Jan 23
ELV
Earnings call transcript
2022 Q3
19 Oct 22
ELV
Earnings call transcript
2022 Q2
20 Jul 22
ELV
Earnings call transcript
2022 Q1
20 Apr 22
ELV
Earnings call transcript
2021 Q4
26 Jan 22
ELV
Earnings call transcript
2021 Q3
20 Oct 21
Latest ownership filings
4
Charles Morgan Kendrick JR
12 Mar 24
4
Ronald W Penczek
8 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
4
Ronald W Penczek
5 Mar 24
4
Blair Williams Todt
5 Mar 24
4
RATNAKAR LAVU
5 Mar 24
4
Charles Morgan Kendrick JR
5 Mar 24
4
Felicia F Norwood
5 Mar 24
4
Peter D Haytaian
5 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2023
61.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1335 |
Opened positions | 182 |
Closed positions | 332 |
Increased positions | 490 |
Reduced positions | 470 |
13F shares | Current |
---|---|
Total value | 58.87 tn |
Total shares | 144.13 mm |
Total puts | 325.66 k |
Total calls | 181.49 k |
Total put/call ratio | 1.8 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 21.23 mm | $10.01 tn |
T. Rowe Price | 11.92 mm | $5.62 bn |
STT State Street | 10.41 mm | $4.91 tn |
Wellington Management | 5.91 mm | $2.79 tn |
Sanders Capital | 4.46 mm | $2.10 tn |
FMR | 3.97 mm | $1.87 tn |
Capital International Investors | 3.37 mm | $1.59 tn |
Baillie Gifford & Co | 3.09 mm | $1.46 tn |
MS Morgan Stanley | 2.90 mm | $1.37 tn |
NTRS Northern Trust | 2.33 mm | $1.10 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Mar 24 | Charles Morgan Kendrick JR | Common Stock | Sell | Dispose S | No | No | 500.46 | 2,432 | 1.22 mm | 15,840 |
6 Mar 24 | Ronald W Penczek | Common Stock | Sell | Dispose S | No | No | 504.58 | 916 | 462.20 k | 1,764 |
1 Mar 24 | Ronald W Penczek | Common Stock | Grant | Acquire A | No | No | 0 | 1,046 | 0.00 | 2,680 |
1 Mar 24 | Ronald W Penczek | Common Stock | Grant | Acquire A | No | No | 0 | 226 | 0.00 | 1,634 |
1 Mar 24 | Ronald W Penczek | Common Stock | Payment of exercise | Dispose F | No | No | 499.11 | 383 | 191.16 k | 1,408 |
1 Mar 24 | Ronald W Penczek | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 499.11 | 867 | 432.73 k | 867 |
1 Mar 24 | Blair Williams Todt | Common Stock | Grant | Acquire A | No | No | 0 | 6,537 | 0.00 | 17,156 |
1 Mar 24 | Blair Williams Todt | Common Stock | Grant | Acquire A | No | No | 0 | 2,154 | 0.00 | 10,619 |
1 Mar 24 | Blair Williams Todt | Common Stock | Payment of exercise | Dispose F | No | No | 499.11 | 3,650 | 1.82 mm | 8,465 |
1 Mar 24 | Blair Williams Todt | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 499.11 | 8,312 | 4.15 mm | 8,312 |
News
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
13 Mar 24
Analyst Scoreboard: 6 Ratings For Elevance Health
6 Mar 24
Barclays Initiates Coverage On Elevance Health with Overweight Rating, Announces Price Target of $584
6 Mar 24
The Centers For Medicare & Medicaid Services Informed Elevance Health's Four Medicare Advantage Contracts Will Have A Higher 2024 Star Rating Because Of Updated The Original Ratings Announced In October 2023 - 8K
4 Mar 24
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,500 Today
29 Feb 24
Press releases
Elevance Health Announces Closing of Paragon Healthcare Acquisition
11 Mar 24
Performant Financial Corporation Announces the Appointment of Dr. Shantanu Agrawal to Its Board of Directors
6 Mar 24
Elevance Health Announces Appearance at the Cowen 44th Annual Health Care Conference
22 Feb 24
Elevance Health Announces Appearance at Barclays 26th Annual Global Healthcare Conference
22 Feb 24
Elevance Health Named in Top 10 of America's Most JUST Companies by JUST Capital and CNBC
5 Feb 24